HOUSTON, TX, Autoimmunity BioSolutions, a biotechnology company developing a personalized, genetically-guided immuno-corrective therapy designed to normalize elevated levels of soluble IL7 receptor.
Continue Reading
Sign up for FREE to read the full article and access 129K+ alternative investment headlines.